SHILPAMED.NSSHILPAMED.NSNSE
Loading
EPS Growth Under PressureDecelerating
Percentile Rank93
5Y CAGR+25.0%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

5Y CAGR
+25.0%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
3x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025119.07%
2024197.87%
2023-151.65%
2022-59.96%
2021-5.33%
202039.07%
20195.36%
2018-5.36%
20171.62%
201641.56%